Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon

Author:

Andrade Alan RodriguesORCID,Leitão Daniel da Silva,Paz Igor Penha,Evangelista Talitta Ribeiro,Mello Vanessa Joia de,Hamoy Moisés

Publisher

Elsevier BV

Subject

Hematology,Immunology and Allergy

Reference24 articles.

1. Adherence and persistence among chronic myeloid leukemia patients during second-line tyrosine kinase inhibitor treatment;Trivedi;J Manag Care Pharm [Internet],2014

2. Factors influencing adherence to imatinib in indian chronic myeloid leukemia patients: a cross-sectional study;Kapoor;Mediterr J Hematol Infect Dis [Internet],2015

3. Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia;Jabbour;Am J Hematol [Internet],2012

4. Patient adherence and persistence with imatinib, nilotinib, dasatinib in clinical practice;Santoleri;PLOS ONE [Internet],2013

5. Low educational level but not low income impairs the achievement of cytogenetic remission in chronic myeloid leukemia patients treated with imatinib in Brazil;Rego;Clinics [Internet],2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3